Posted by Michael Wonder on 12 Apr 2016
TGA publishes 2 new AusPARs
12 April 2016 - The TGA has published Australian Public Assessment Reports (AusPARs) for eltrombopag olamine (Revolade) and the biosimilar for follitropin alfa (Bemfola/Afolia).
An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.
